Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inhibrx Biosciences

15.37
+0.98006.81%
Post-market: 15.830.4600+2.99%17:43 EDT
Volume:114.31K
Turnover:1.74M
Market Cap:222.49M
PE:0.14
High:15.59
Open:14.43
Low:14.43
Close:14.39
Loading ...
Oct 28, 2021

Major Issues Report

8-K - Current report
Oct 12, 2021

Major Issues Report

8-K - Current report
Sep 03, 2021

Major Issues Report

Inhibrx, Inc.
Sep 03, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2021

Major Issues Report

8-K - Current report
Jun 21, 2021

Major Issues Report

8-K - Current report
Jun 09, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 13, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 12, 2021

Major Issues Report

8-K - Current report
Mar 12, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals